{"id":71250,"date":"2026-03-03T16:43:10","date_gmt":"2026-03-03T11:13:10","guid":{"rendered":"https:\/\/corpbiz.io\/learning\/?p=71250"},"modified":"2026-03-06T10:28:51","modified_gmt":"2026-03-06T04:58:51","slug":"cdsco-boosts-pharma-exports","status":"publish","type":"post","link":"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/","title":{"rendered":"CDSCO Eases Export NOC for SRA Countries to Boost Pharma Exports"},"content":{"rendered":"\n<p>India is one of the largest exporters of generic drugs worldwide. Many regulated markets, like the US and Europe, are demanding Indian drugs. Regarding this, the Central Drugs Standard Control Organization (CDSCO) has taken an important NOC relief decision. A separate Export NOC is no longer required for exporting drugs to SRA countries. This will make the export process quick and less cumbersome.<\/p>\n\n\n\n<p>This decision will reduce both time and cost for Indian pharma companies, increasing their competitiveness in the global market. In this article, we will discuss the CDSCO\u2019s new rules, their impact, and what exporters can do.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title ez-toc-toggle\" style=\"cursor:pointer\">Page Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Role_of_CDSCO_in_Pharma_Regulation\" >Role of CDSCO in Pharma Regulation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#What_is_an_Export_NOC\" >What is an Export NOC?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Key_Aspects_of_CDSCOs_New_Decision\" >Key Aspects of CDSCO&#8217;s New Decision<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Talk_To_Expert\" >Talk To Expert<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Get_Expert_help_on_CDSCO_Export_NOC_Help\" >Get Expert help on CDSCO Export NOC Help<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Which_Countries_are_included_in_the_SRA_Category\" >Which Countries are included in the SRA Category?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#How_will_this_Reform_Speed_up_Pharma_Exports\" >How will this Reform Speed up Pharma Exports?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Quality_and_GMP_Supervision_will_Remain_Strict_as_before\" >Quality and GMP Supervision will Remain Strict as before<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Industry_Response_and_Market_Impact\" >Industry Response and Market Impact<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Broader_Regulatory_Reforms_by_CDSCO\" >Broader Regulatory Reforms by CDSCO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Important_Things_Exporters_Need_to_Do\" >Important Things Exporters Need to Do<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Future_Outlook_for_Indian_Pharma_Exports\" >Future Outlook for Indian Pharma Exports<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Conclusion\" >Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/corpbiz.io\/learning\/cdsco-boosts-pharma-exports\/#Frequently_Asked_Questions\" >Frequently Asked Questions<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Role_of_CDSCO_in_Pharma_Regulation\"><\/span>Role of CDSCO in Pharma Regulation<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The CDSCO is the central drug regulatory organization of India. It oversees the safety, quality, and approval processes of drugs nationwide. The organization also plays an important role in pharma exports. <strong><a href=\"https:\/\/corpbiz.io\/cdsco-registration\">CDSCO registration<\/a> <\/strong>is of utmost importance in the pharma sector.<\/p>\n\n\n\n<p><strong>Key Functions of CDSCO:<\/strong><\/p>\n\n\n\n<p>Look for the key functions of CDSCO mentioned below:<\/p>\n\n\n\n<ul>\n<li><strong>Drug Approval: <\/strong>It is required for the scientific evaluation and approval of new drugs before they are brought to the market.<\/li>\n\n\n\n<li><strong>Export Control:<\/strong> It ensures compliance with regulations for drugs sent to the international market.<\/li>\n\n\n\n<li><strong>Quality Supervision: <\/strong>Monitors whether GMP and other standards are maintained.<\/li>\n\n\n\n<li><strong>Balance of Patient Safety and Business: <\/strong>The organization ensures patient safety and adapts to an easy-to-do environment for the industry.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_an_Export_NOC\"><\/span>What is an Export NOC?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>An Export No Objection Certificate (NOC) must be obtained from CDSCO before sending drugs abroad. This NOC was mandatory for exports to most regulated markets, including SRA countries.<\/p>\n\n\n\n<p>Companies had to submit detailed documents to get a valid NOC for one year. This process was time-consuming and involved a lot of paperwork. It was a huge administrative burden.<\/p>\n\n\n\n<p>Exporters complained that additional approval often delayed deliveries and increased costs, even though the importing country also had its own regulatory system. So, this rule became controversial.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Aspects_of_CDSCOs_New_Decision\"><\/span>Key Aspects of CDSCO&#8217;s New Decision<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>CDSCO&#8217;s recent move is seen as a major policy change for Indian pharma exports. The decision has reduced unnecessary approvals for low-risk cases, but quality control remains as strong as before.<\/p>\n\n\n\n<p><em>Here are a few key aspects based on the decision of the CDSCO authority:<\/em><strong><\/strong><\/p>\n\n\n\n<ul>\n<li><strong>Export NOC Abolition: <\/strong>Exports to SRA countries no longer require a mandatory NOC.<\/li>\n\n\n\n<li><strong>Auto-acknowledgement mechanism:<\/strong> Exporters only need to provide notification and receive automatic recognition.<\/li>\n\n\n\n<li><strong>Risk-based regulation: <\/strong>Facilitating low-risk activities and keeping a close eye on high-risk ones.<\/li>\n\n\n\n<li><strong>Ease of Doing Business Alignment: <\/strong>This move is part of the government&#8217;s initiative to make it easier to do business.<\/li>\n\n\n\n<li><strong>Notification soon:<\/strong> The rules are expected to come into effect through a formal notification.<\/li>\n<\/ul>\n\n\n\n<h2><span class=\"ez-toc-section\" id=\"Talk_To_Expert\"><\/span>Talk To Expert<span class=\"ez-toc-section-end\"><\/span><\/h2><div class=\"calling-person blog_cta my-4\"> \n    <div class=\"row\"> \n        <div class=\"col-xs-12 col-sm-12 col-md-12 col-lg-12\"> \n            <div class=\"d-flex flex-nowrap\"> \n                <div class=\"user-online\"> <img decoding=\"async\" src=\"https:\/\/corpbiz.io\/img\/user.jpg\" alt=\"corpbiz\"> <\/div> \n                <div class=\"user-online-details ms-3 align-self-center\"> \n                    <h2 class=\"text-white mt-0\"><span class=\"ez-toc-section\" id=\"Get_Expert_help_on_CDSCO_Export_NOC_Help\"><\/span>Get Expert help on CDSCO Export NOC Help<span class=\"ez-toc-section-end\"><\/span><\/h2> \n                    <p class=\"mt-3\"><i class=\"fa fa-star\"><\/i><i class=\"fa fa-star\"><\/i><i class=\"fa fa-star\"><\/i><i \n\n                            class=\"fa fa-star\"><\/i><i class=\"fa fa-star-half-full\"><\/i><span \n\n                            class=\"ms-2 text-white\">(4.8)<\/span><\/p> \n                <\/div> \n            <\/div> \n        <\/div> \n        <div class=\"col-xs-12 col-sm-12 col-md-12 col-lg-8 mx-auto\"> \n            <div class=\"d-flex justify-content-between call-chat\"> <a href=\"tel:919121230280\"> <span>Call Now \n\n            <\/span><img decoding=\"async\" class=\"ms-2\" src=\"https:\/\/corpbiz.io\/admin\/style\/images\/userfiles\/image\/new_call_icon.png\" \n\n                alt=\"Call With \" width=\"32px\"> \n        <\/a> <a href=\"https:\/\/api.whatsapp.com\/send?phone=919289379709&#038;text=Hi+Corpbiz.+I+am+Looking+For+CDSCO+Export+NOC+Help\" target=\"_blank\" rel=\"noopener\"> <span>Chat With Us<\/span><img decoding=\"async\" class=\"ms-2\" \n\n                src=\"https:\/\/corpbiz.io\/img\/chat-with-expert.png\" alt=\"Chat With \" width=\"32px\"> <\/a> <\/div> \n        <\/div> \n    <\/div> \n<\/div>\n\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Which_Countries_are_included_in_the_SRA_Category\"><\/span>Which Countries are included in the SRA Category?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Stringent Regulatory Authority refers to the drug regulatory bodies of the countries that verify the safety and quality of drugs with very strict standards. Approval in these countries indicates that the quality of the product is globally acceptable.<\/p>\n\n\n\n<p>The key SRA markets for Indian pharma exports are the following:<\/p>\n\n\n\n<ul>\n<li>United States<\/li>\n\n\n\n<li>European Union<\/li>\n\n\n\n<li>United Kingdom<\/li>\n\n\n\n<li>Japan<\/li>\n\n\n\n<li>Canada<\/li>\n\n\n\n<li>Australia<\/li>\n<\/ul>\n\n\n\n<p>These countries already have strong regulatory systems. The exported products undergo multi-level verification. So, even without an additional export of NOC, the safety risk is very low.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_will_this_Reform_Speed_up_Pharma_Exports\"><\/span>How will this Reform Speed up Pharma Exports?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The relaxation of the Export NOC will make the export process much easier for Indian pharma companies. Where earlier they had to wait for additional approval, now faster shipments will be possible. This will enable companies to keep pace with international demand faster.<\/p>\n\n\n\n<p>Below are the key benefits of Export NOC Relief:<\/p>\n\n\n\n<ul>\n<li><strong>Less paperwork: <\/strong>There will be less unnecessary documentation.<\/li>\n\n\n\n<li><strong>Faster shipment: <\/strong>Goods can be shipped more quickly because there is no waiting for approval.<\/li>\n\n\n\n<li><strong>Less congestion at ports: <\/strong>Delays at the port level will be reduced.<\/li>\n\n\n\n<li><strong>Faster response to global demand: <\/strong>Urgent orders will be fulfilled faster.<\/li>\n\n\n\n<li><strong>Benefits of handling multiple shipments: <\/strong>The work of large exporters will be easier.<\/li>\n\n\n\n<li><strong>Increased export competition:<\/strong> Indian companies will have a stronger position in the international market.<\/li>\n<\/ul>\n\n\n\n<p><strong>Read more &#8211;<a href=\"https:\/\/corpbiz.io\/learning\/cdsco-compliance-for-startups-new-manufacturers\/\"> CDSCO Compliance for Startups &amp; New Manufacturers<\/a><\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Quality_and_GMP_Supervision_will_Remain_Strict_as_before\"><\/span>Quality and GMP Supervision will Remain Strict as before<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The regulatory body has simplified rules without compromising quality. Compliance with Good Manufacturing Practices (GMP) will remain mandatory, and surveillance of manufacturing units has been strengthened. Inspections are being increased as per the revised Schedule M.<\/p>\n\n\n\n<p>In addition, risk-based audits and strict monitoring of Not of Standard Quality (NSQ) products are being carried out. Strict action will be taken in case of violation of the rules.<\/p>\n\n\n\n<p>This balanced approach aims to facilitate exports on one hand while maintaining confidence in Indian medicines in the global market.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Industry_Response_and_Market_Impact\"><\/span>Industry Response and Market Impact<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The pharma industry has welcomed the decision as a positive step. It will solve a real problem and make the export process more efficient.<\/p>\n\n\n\n<p><strong>Key aspects of the industry response:<\/strong><\/p>\n\n\n\n<ul>\n<li><strong>Positive response:<\/strong> Large and medium exporters have supported the decision.<\/li>\n\n\n\n<li><strong>Cost reduction: <\/strong>Operational costs will be reduced by eliminating unnecessary approvals.<\/li>\n\n\n\n<li><strong>Quick turnaround:<\/strong> Shipment preparation and dispatch time will be reduced.<\/li>\n\n\n\n<li><strong>Support for small manufacturers: <\/strong>Small and medium-sized pharmaceutical manufacturing organizations have been demanding this change for a long time.<\/li>\n\n\n\n<li><strong>Alignment with global practices:<\/strong> The policy is aligned with international regulatory trends.<\/li>\n\n\n\n<li><strong>Acceleration in generic exports: <\/strong>According to experts, this will further increase the export of Indian generic medicines.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Broader_Regulatory_Reforms_by_CDSCO\"><\/span>Broader Regulatory Reforms by CDSCO<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The decision to relax the export of NOC is not an isolated step. It is part of the recent reforms of CDSCO. The regulatory body is simplifying the process by removing unnecessary approvals for low-risk cases.<\/p>\n\n\n\n<p>Earlier, the BA\/BE NOC requirement was removed for low-risk export research. The requirement for a <strong><a href=\"https:\/\/corpbiz.io\/cdsco-test-license\">CDSCO test license<\/a> <\/strong>up to the pre-clinical stage has also been abolished. In addition, the time frame for approval of Investigational New Drugs (IND) and Permission for Biological Trials (PBT) has been reduced.<\/p>\n\n\n\n<p>These steps show that the regulatory system is now operating in a risk-based manner. The larger goal of the government is to ease business, increase innovation, and make India\u2019s pharma industry stronger globally.<\/p>\n\n\n\n<div style=\"text-align:center; margin: 30px 0;\">\n  <a href=https:\/\/api.whatsapp.com\/send?phone=919289379709&#038;text=Hi+Corpbiz.+I+am+Looking+For+CDSCO+Export+NOC+Help\"\n     style=\"\n       display: inline-block;\n       padding: 16px 36px;\n       background: linear-gradient(135deg, #1A73E8, #1558D6);\n       color: #ffffff;\n       text-decoration: none;\n       font-size: 18px;\n       font-weight: 600;\n       border-radius: 50px;\n       box-shadow: 0 6px 18px rgba(26, 115, 232, 0.35);\n       transition: all 0.3s ease;\n       letter-spacing: 0.5px;\n     \"\n     onmouseover=\"this.style.transform='translateY(-3px)'; this.style.boxShadow='0 10px 24px rgba(26,115,232,0.45)'\"\n     onmouseout=\"this.style.transform='translateY(0)'; this.style.boxShadow='0 6px 18px rgba(26,115,232,0.35)'\"\n  >\n    Book a 1:1 Virtual Meeting\n  <\/a>\n<\/div>\n\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Important_Things_Exporters_Need_to_Do\"><\/span>Important Things Exporters Need to Do<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>While the rules are simplified, exporters need to be vigilant and prepared. The following points should be kept in mind in particular:<\/p>\n\n\n\n<ul>\n<li><strong>NOC required:<\/strong> An export of NOC may still be required in countries other than SRA or in special cases.<\/li>\n\n\n\n<li><strong>Document maintenance: <\/strong>All product, batch, and export-related documents should be kept up to date.<\/li>\n\n\n\n<li><strong>Approval of importing country: <\/strong>In case of exporting the unapproved drugs, permission of the destination country is mandatory.<\/li>\n\n\n\n<li><strong>Follow best practices: <\/strong>Strictly follow GMP and quality systems.<\/li>\n\n\n\n<li><strong>Internal compliance checklist: <\/strong>Regularly audit and review documents.<\/li>\n\n\n\n<li><strong>Seek expert help: <\/strong>It is always better to seek help of an experienced regulatory consultant.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Future_Outlook_for_Indian_Pharma_Exports\"><\/span>Future Outlook for Indian Pharma Exports<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The CDSCO\u2019s new policy changes are expected to increase India&#8217;s drug exports to regulated markets. Companies will be able to send products to the market faster by reducing the export NOC requirement. This will strengthen India&#8217;s position as a reliable supplier of generic drugs in the world.<\/p>\n\n\n\n<p>The industry is moving towards Pharma 4.0, data-driven quality control, and automated processes. This balance of simple rules and strict monitoring will increase international trust in the long run.<\/p>\n\n\n\n<p>If implemented properly, these reforms can pave the way for strong growth in Indian pharma exports.<\/p>\n\n\n\n<p><strong>Read more &#8211;<a href=\"https:\/\/corpbiz.io\/learning\/cdsco-releases-draft-guidelines-on-good-clinical-practices\/\"> CDSCO Releases Draft Guidelines on Good Clinical Practices<\/a><\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>CDSCO\u2019s decision to relax export NOC is a big positive step for the Indian pharma industry. It will make the export process faster and easier, but the quality monitoring will remain as stringent as before. So, companies will now have the opportunity to reach the global market in less time.<\/p>\n\n\n\n<p>However, simple rules do not mean less responsibility. Proper documentation, GMP compliance, and meeting the conditions of the importing country are still very important.<\/p>\n\n\n\n<p>If you want to be sure about pharma exports, CDSCO compliance, or regulatory support, always seek expert advice.<strong> <a href=\"https:\/\/corpbiz.io\/\">Corpbiz<\/a> <\/strong>is ready to provide you with complete end-to-end support. So, take the initiative today and make your export process safe.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span>Frequently Asked Questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"saswp-faq-block-section\"><ol style=\"list-style-type:none\"><li style=\"list-style-type: none\"><h3>What is the Export NOC in Pharmaceuticals?<\/h3><p class=\"saswp-faq-answer-text\">Export NOC stands for No Objection Certificate. Earlier, permission was required before sending medicines abroad by the CDSCO. It ensures that the exported medicines are properly manufactured and safe. However, obtaining this permission required a lot of paperwork and took a lot of time, so companies often faced delays.<\/p><li style=\"list-style-type: none\"><h3>Has CDSCO completely removed Export NOC requirements?<\/h3><p class=\"saswp-faq-answer-text\">Export NOC has not been removed in all cases. The CDSCO has relaxed this obligation only for the export of approved products to SRA countries. Permission may still be required in some other situations. So, exporters should carefully check the rules before each shipment.<\/p><li style=\"list-style-type: none\"><h3>Which countries are covered under the SRA list?<\/h3><p class=\"saswp-faq-answer-text\">The SRA list includes countries that have very strong regulatory systems. These include the US, the European Union, the UK, Japan, Canada, and Australia. These countries test the quality of medicines themselves. So, India has reduced the requirement for additional NOC. As a result, the export process for Indian companies in this market has now become much easier.<\/p><li style=\"list-style-type: none\"><h3>Do exporters still need to inform CDSCO before shipment?<\/h3><p class=\"saswp-faq-answer-text\">Yes, exporters still must inform, but the process has become easier. Earlier, they had to get a full NOC. Now, the company only must submit a notification, and an automatic acknowledgement is obtained from the CDSCO. It is very important to submit the information correctly, as there may be problems later.<\/p><li style=\"list-style-type: none\"><h3>Will quality checks be reduced after this relaxation?<\/h3><p class=\"saswp-faq-answer-text\">No, quality checks have not been reduced. The CDSCO has clearly stated that GMP and other inspections will continue as before. In many cases, surveillance has increased further. This change reduces unnecessary paperwork. So, companies will have to maintain quality as before.<\/p><li style=\"list-style-type: none\"><h3>How will NOC Relief by CDSCO benefit small pharma exporters?<\/h3><p class=\"saswp-faq-answer-text\">The NOC relief by CDSCO is very helpful for small exporters. Earlier, getting an NOC was time-consuming and costly. This was a big pressure for small companies. Now they can ship products faster, and the cost will be reduced. This will make it easier to compete in the international market. Especially those who send multiple small consignments will benefit the most.<\/p><li style=\"list-style-type: none\"><h3>Is the new rule applicable to unapproved drugs?<\/h3><p class=\"saswp-faq-answer-text\">Generally, this facility applies to approved drugs. If a drug is not approved in India, then regulatory approval from the importing country may still be required. So, it is necessary to check the rules before exporting unapproved products. It is safe to consult a regulatory expert.<\/p><li style=\"list-style-type: none\"><h3>When will the new CDSCO notification take effect?<\/h3><p class=\"saswp-faq-answer-text\">The new CDSCO change will come into effect through a government notification. The CDSCO has already started the process of implementing it. However, the exact effective date is mentioned in the notification. So, exporters should check the latest updates so that they can follow the new rules properly.<\/p><li style=\"list-style-type: none\"><h3>How does Export NOC reform support ease of doing business?<\/h3><p class=\"saswp-faq-answer-text\">The export NOC reform makes it easier to do business with less paperwork and waiting for approval. Companies can send orders faster. This saves both time and money. The government aims to simplify the process in low-risk areas and keep a watch on key areas. This strikes a balance between industry and regulation.<\/p><li style=\"list-style-type: none\"><h3>How can companies ensure compliance with the new system?<\/h3><p class=\"saswp-faq-answer-text\">Although the rules are simple, it is important to be careful. The company must manufacture in accordance with GMP and keep all records properly. Notifications have to be submitted to the CDSCO on time. Regular internal audits are also good practices. Taking help from experts, when necessary, reduces the risk of mistakes and makes the export process smoother.<\/p><\/ul><\/div>\n\n\n<div style=\"text-align:center; margin: 30px 0;\">\n  <a href=https:\/\/api.whatsapp.com\/send?phone=919289379709&#038;text=Hi+Corpbiz.+I+am+Looking+For+CDSCO+Export+NOC+Help\"\n     style=\"\n       display: inline-block;\n       padding: 16px 36px;\n       background: linear-gradient(135deg, #1A73E8, #1558D6);\n       color: #ffffff;\n       text-decoration: none;\n       font-size: 18px;\n       font-weight: 600;\n       border-radius: 50px;\n       box-shadow: 0 6px 18px rgba(26, 115, 232, 0.35);\n       transition: all 0.3s ease;\n       letter-spacing: 0.5px;\n     \"\n     onmouseover=\"this.style.transform='translateY(-3px)'; this.style.boxShadow='0 10px 24px rgba(26,115,232,0.45)'\"\n     onmouseout=\"this.style.transform='translateY(0)'; this.style.boxShadow='0 6px 18px rgba(26,115,232,0.35)'\"\n  >\n    Book a 1:1 Virtual Meeting\n  <\/a>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>India is one of the largest exporters of generic drugs worldwide. Many regulated markets, like the US and Europe, are demanding Indian drugs. Regarding this, the Central Drugs Standard Control Organization (CDSCO) has taken an important NOC relief decision. A separate Export NOC is no longer required for exporting drugs to SRA countries. This will [&hellip;]<\/p>\n","protected":false},"author":77,"featured_media":71253,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[2358],"tags":[],"acf":{"service_id":"508"},"authorName":"Vaibhav Rathi","authorImageUrl":"https:\/\/corpbiz.io\/learning\/wp-content\/uploads\/2026\/02\/20230614064335_vaibhav-rathi.jpg","authorDescription":"Vaibhav Rathi is a corporate lawyer and legal writer who bring 10+ years of experience to his craft. His expertise encompasses a wide range of topics, including mergers and acquisitions, corporate governance, and compliance-related issues. His perfect blend of fantastic writing skills and legal expertise helps him create compelling articles that keep the readers hooked till the end. His passion for writing drives him, and he likes spilling his thoughts on paper.","postViews":1443,"readingTime":4,"_links":{"self":[{"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/posts\/71250"}],"collection":[{"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/users\/77"}],"replies":[{"embeddable":true,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/comments?post=71250"}],"version-history":[{"count":6,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/posts\/71250\/revisions"}],"predecessor-version":[{"id":71258,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/posts\/71250\/revisions\/71258"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/media\/71253"}],"wp:attachment":[{"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/media?parent=71250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/categories?post=71250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/tags?post=71250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}